Document is current
Any future updates will be listed below
-
Authors
Chen, Xiangqi
Piao, Mingjian
Zhou, Zixiang
Wang, Shanshan
Li, Shuofeng
Zhang, Nan
Sun, Boyu
Liu, Kai
Yang, Xu
Yang, Xiaobo
Shi, Xiaohua
Zhu, Chengpei
Zhao, Haitao
- License Information
-
More Information
Article History
Received: 20 May 2025
Accepted: 16 September 2025
First Online: 9 October 2025
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki, and was approved by the Institutional Review Board of Peking Union Medical College Hospital (IRB No. JS-1391). All patients provided written informed consent before receiving combined target/ICI antibody treatment.
: The authors declare no competing interests.
